4MOORE NA, LEANDER JD, BENVENGA MJ, et al. Behavioral pharmacology of olanzapine: a novel antipsyehotie drug [J]. J Clin Psychiatry, 1997,58 Suppl 10: 37-44.
5TOLLEFSON GD, BEASLEY CM, TRAN PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffectire and schizophreniform disorders: results of an international collaborative trial[J]. Am J Psychiatry ,1997,154(4):457-465.
7GLAZER WM. Olanzapine and the new generation of antipsychotic agents:patterns of use [J]. J Clin Psychiatry, 1997,58 Suppl 10:18-21.
8Kim YK.Lee MS.Suh KY.Decreased interleukin-2 production in Korean schizophrenic patients[J].Biol Psychiatry,1998,43(9):701-704.
9Naudia J.Mege JL.Azorin JM,et al.Elevated circulating levels of IL-6 in schizophrenia[J].Schizophr Res,1996,20(3):269-273.
10Arolt V, Rothermundt M, Wandinger KP.et al.Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment[J].Mol Psychiatry,2000,5(2): 150-158.
